Skip to main content

 4MBJ | pdb_00004mbj

Human B-Raf Kinase Domain in Complex with an Imidazopyridine-based Inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.60 Å
  • R-Value Free: 
    0.328 (Depositor), 0.263 (DCC) 
  • R-Value Work: 
    0.276 (Depositor) 
  • R-Value Observed: 
    0.276 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 4MBJ

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history. 

Literature

Imidazo[4,5-b]pyridine inhibitors of B-Raf kinase.

Newhouse, B.J., Wenglowsky, S., Grina, J., Laird, E.R., Voegtli, W.C., Ren, L., Ahrendt, K., Buckmelter, A., Gloor, S.L., Klopfenstein, N., Rudolph, J., Wen, Z., Li, X., Feng, B.

(2013) Bioorg Med Chem Lett 23: 5896-5899

  • DOI: https://doi.org/10.1016/j.bmcl.2013.08.086
  • Primary Citation Related Structures: 
    4MBJ

  • PubMed Abstract: 

    This Letter details the synthesis and evaluation of imidazo[4,5-b]pyridines as inhibitors of B-Raf kinase. These compounds bind in a DFG-in, αC-helix out conformation of B-Raf, which is a binding mode associated with significant kinase selectivity. Structure-activity relationship studies involved optimization of the ATP-cleft binding region of these molecules, and led to compound 23, an inhibitor with excellent enzyme/cell potency, and kinase selectivity.


  • Organizational Affiliation: 
    • Array BioPharma Inc., 3200 Walnut Street, Boulder, CO 80301, USA. Electronic address: bnewhouse@arraybiopharma.com.

Macromolecule Content 

  • Total Structure Weight: 70.41 kDa 
  • Atom Count: 4,420 
  • Modeled Residue Count: 545 
  • Deposited Residue Count: 608 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Serine/threonine-protein kinase B-raf
A, B
304Homo sapiensMutation(s): 0 
Gene Names: BRAF, BRAF1, RAFB1
EC: 2.7.11.1
UniProt & NIH Common Fund Data Resources
Find proteins for P15056 (Homo sapiens)
Explore P15056 
Go to UniProtKB:  P15056
PHAROS:  P15056
GTEx:  ENSG00000157764 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP15056
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
DFS

Query on DFS



Download:Ideal Coordinates CCD File
C [auth A],
D [auth B]
2,6-difluoro-N-(1H-imidazo[4,5-b]pyridin-6-yl)-3-[(propylsulfonyl)amino]benzamide
C16 H15 F2 N5 O3 S
CWDHWLRBSAIDBH-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.60 Å
  • R-Value Free:  0.328 (Depositor), 0.263 (DCC) 
  • R-Value Work:  0.276 (Depositor) 
  • R-Value Observed: 0.276 (Depositor) 
Space Group: P 41 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 106.97α = 90
b = 106.97β = 90
c = 152.44γ = 90
Software Package:
Software NamePurpose
Blu-Icedata collection
CNSrefinement
MOSFLMdata reduction
SCALAdata scaling
CNSphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2013-10-02
    Type: Initial release
  • Version 1.1: 2013-11-06
    Changes: Database references
  • Version 1.2: 2024-02-28
    Changes: Data collection, Database references, Derived calculations